| PSN Editor's Award Received By Rutgers College Of Nursing Professor And Her 2 Students The American Society of Plastic Surgical Nurses presented its Plastic Surgical Nurses (PSN) Editor's Award to Marlene Rankin, a Rutgers College of Nursing faculty member, and her two co-authors, during its annual convention in Chicago Nov. 1. medicalnewstoday.com |
Surgical Safety Checklist Drops Deaths And Complications By More Than One Third An international pilot study involving the Toronto General Hospital (TGH), a teaching hospital affiliated with the University of Toronto, and other hospitals from around the world, has found that using a Surgical Patient Safety Checklist significantly reduces surgical complications and mortality. The study, led by the World Health Organization (WHO) and Dr. Atul Gawande of the Harvard School of Public Health, appears in the New England Journal of Medicine's ( medicalnewstoday.com |
SafeStitch Medical, Inc. Receives FDA Clearance To Market The AMID StaplerTM For Hernia Repairs SafeStitch Medical, Inc. (OTCBB:SFES) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to market its AMID StaplerTM in the U.S. with the intended use in general surgery procedures for fixation of mesh, in the repair of hernia defects and in other surgical specialties for the approximation of tissues, including skin. medicalnewstoday.com |
Dune Medical Completes Enrollment In MarginProbe(TM) Pivotal Trial For Real Time Detection Of Cancer During Breast Conservation Surgery Dune Medical Devices announced the completion of patient enrollment in the MarginProbe™ pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the tumor from the breast... mnt.to |
Ethicon Submits Biologic License Application To The FDA For The Fibrin Pad Ethicon, Inc., a worldwide leader in surgical care, announced that the company has submitted a Biologic License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the Fibrin Pad, a novel product candidate that combines Ethicon's biomaterials and plasma-derived biologics (Human Fibrinogen and Human Thrombin), to aid in stopping soft tissue bleeding during surgery... mnt.to |